ClinicalTrials.gov
public full text
Public Domain
A Study to Evaluate the Efficacy and Safety of QL1706 Injection in Patients With Solid Tumors
This a multi-center, open-label, non-randomized phaseⅠb trail. The purpose of this study was to evaluate the efficacy and safety of QL1706 in patients with advanced solid tumors and to investigate the immunogenicity and pharmacokinetic characteristics of QL1706.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Safety and Efficacy Study of First-line Treatment With QL1706 Plus Chemotherapy in Extensive-Stage Small Cell Lung Cancer#1125080
- A Study of QL1706 Combined With Chemotherapy in Advanced Non-small Cell Lung Cancer#849974
- QL1706 in the Treatment of Advanced Bone and Soft Tissue Sarcoma#1125909
- A Study of QL1706H in Patients With Advanced Solid Tumors#870973
- First in Human Study of QLS5316 in Solid Tumors#896825
Record · ID 892838
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive